Topic

FDG-PET


RSNA, Toshiba award Seed and Resident Grant winners

Industry News | Thursday, August 19 2010
Healthcare IT company Toshiba America Medical Systems and the Radiological Society of North America (RSNA) have announced the winners of the 2010 Toshiba America Medical Systems/RSNA Research & Education (R&E) Foundation grants.
 

Study: FDG-PET + MR fusion helps evaluate breast cancer

Clinical Studies | Tuesday, May 11 2010
Fusion of prone 18F-FDG PET and MR breast scans increases the positive predictive value and specificity for patients in whom the MR outcome alone would be nonspecific, according to research published April 23 in the Breast Journal.
 

Study: FDG-PET/CT predicts responders, non-responders in bone sarcoma

Clinical Studies | Tuesday, April 27 2010
FDG-PET allows an accurate assessment of histopathologic response to neoadjuvant treatment and can identify histopathologic responders and non-responders in adult primary bone sarcoma patients, according to a study published April 18 in Sarcoma.
 

JNM Feature: FDG PET guided management reduces cardiac events

Top Stories | Tuesday, April 06 2010
Written by Manjula Puthenedam
A significant reduction in cardiac events was observed in patients with 18F-FDG PET–assisted management, compared with patients who received standard care in an experienced center with ready access to 18F-FDG and integration with imaging, heart failure and revascularization teams, according to research published in the April issue of the Journal of Nuclear Medicine.
 

JNM: Dual-phase PET predicts prognosis in lung adenocarcinoma

Clinical Studies | Tuesday, March 30 2010
Dual-phase 18F-FDG PET with measurement of the percentage maximal standardized uptake values change may significantly affect the management of patients with lung adenocarcinoma and could be complementary to other well-known factors, according to a study published in the April issue of the Journal of Nuclear Medicine.
 

Cancer: Tomotherapy+concurrent chemotherapy feasible for non-small cell lung cancer

Clinical Studies | Thursday, March 25 2010
The use of helical tomotherapy in patients with inoperable, locally advanced, stage III nonsmall cell lung cancer with concurrent chemotherapy was feasible and resulted in acceptable toxicity, according to the results of a clinical trial published in the January issue of Cancer.
 

Study: Controlling temp prior to PET scan reduces brown fat FDG uptake

Clinical Studies | Friday, March 19 2010
Brown fat 18F-FDG uptake on PET scan may limit the ability to assess for cancer, and the controlled environmental tempature could affect this limitation, according to research published March 16 in Molecular imaging and Biology.
 

Study: FDG-PET scanning reveals neuronal damage in HIV-treated patients

Top Stories | Thursday, March 18 2010
A large proportion of antiretroviral-treated HIV patients exhibit imminent neuronal damage, which is revealed through cerebral FDG-PET scanning abnormalities and elevated TNF alpha and IL-6 levels, according to a study recently published in the Journal of Neuroinflammation.
 

ASCO-GU: PET/CT useful in identifying patients with disseminated seminoma

Conference News | Wednesday, March 10 2010
PET/CT may help identify patients with disseminated seminoma that was not detected by CT scan, according to a study presented last week at the 2010 Genitourinary Cancers Symposium (ASCO-GU) in San Francisco.
 

Study: PET with Pittsburgh tracer sheds light on Alzheimer's treatment

Clinical Studies | Thursday, February 11 2010
PET with 11C-labeled Pittsburgh Compound-B (PIB) is a powerful tool in examining the relationship between amyloid deposits, clinical symptoms and structural and functional brain changes in the normal aging and Alzheimer's disease, according to a survey in a special issue of Behavioral Neurology, released in December 2009.
 

ASCO: Radioimmunotherapy + gemcitabine shows promise for pancreatic cancer

Conference News | Wednesday, January 27 2010
The results of an ongoing phase I/II study for treating advanced pancreatic cancer with a combination therapy of Immunomedics' antibody, clivatuzumab tetraxetan, (90Y-hPAM4) and anticancer drug gemcitabine, which demonstrated therapeutic activity at two 90Y dose levels with minimal hematologic toxicity, was presented with positive findings at the seventh annual Gastrointestinal Cancers Symposium in Orlando, Fla. this week.
 

Radiology: CMS reimbursements helped FDG-PET proliferation following colorectal surgery

Top Stories | Tuesday, January 26 2010
Among Medicare patients who underwent surgery for colorectal cancer resection during the first 18 months of approved Centers for Medicare and Medicaid Services (CMS) coverage for FDG-PET imaging, there was a substantial growth in utilization of FDG-PET within two years of surgery and the highest rates of utilization occurred within six months of surgery, according to a study in the February issue of Radiology.
 

RSNA: PET/CT with C-11 acetate superior to 18F-FDG in prostate cancer imaging

Portal Exclusives | Monday, December 21 2009
PET/CT with C-11 acetate has higher sensitivity compared to 18F-FDG imaging in detecting primary prostate cancer, local recurrence and apparent nodal spread of the disease in both the staging and re-staging patient populations, according to research presented at the 2009 Radiological Society of North America (RSNA) annual conference in Chicago earlier this month.
 

Study: SPECT and PET useful for diagnosing bone and joint infections

Clinical Studies | Monday, December 07 2009
SPECT/CT with In111-WBC combined with 99mTc-MDP or 99mTc-sulfur colloid and FDG-PET seem to be the best imaging techniques for diagnosis of bone and joint infections, according to a review published in the January issue of Seminars in Nuclear Medicine.
 

FMT-PET aids lung cancer predictive capabilities

Portal Exclusives | Tuesday, November 24 2009
Written by Editorial Staff
The uptake of the radiopharmaceutical fluoro methyl tyrosine (FMT) on PET imaging in patients with pulmonary adenocarcinoma is a significant independent predictor of poor prognosis, according to research published in this month’s issue of the Journal of Nuclear Medicine.
 

MTCT: PET monitors gene therapy in glioma

Conference News | Sunday, November 22 2009
PET strategies are very useful in monitoring the distribution and kinetics of vector-mediated gene expression, as well as the response to therapy in malignant glioma, according to a presentation last week at the Molecular Targets and Cancer Therapeutics (MTCT) conference in Boston.
 

Study: PET helps distinguish neurofibroma from sarcoma

Clinical Studies | Tuesday, October 13 2009
FDG-PET is a highly accurate way to distinguish between neurofibromas and sarcoma, according to a study from UCLA’s Jonsson Comprehensive Cancer Center that was published online this week in the Proceedings of the National Academy of Sciences.
 

FDG-PET billing changes due this month

Industry News | Friday, October 02 2009
The Centers for Medicare & Medicaid Services (CMS) has reissued guidance and billing instructions to Medicare Administrative Contractors on its April adjustments to the National Coverage Determination for FDG-PET, set to take place later this month.
 

News & Views

Departments | Tuesday, September 22 2009
Written by Justine Cadet
HIIT070704- CMS supports NCD coverage of FDG-PET for cervical cancer

- OIG cautions CMS about ultrasound overuse
 

CMS supports NCD coverage of FDG-PET for cervical cancer

Top Stories | Monday, August 17 2009
The Centers for Medicare & Medicaid Services (CMS) has proposed a national coverage determination (NCD) of FDG-PET imaging for cervical cancer staging in certain cases, due to its capability to “make meaningful changes in therapeutic management and improve health outcomes.”
 
Web Exclusives

Feature: U.S. needs national strategy to curb imaging overutilization

Medical imaging overutilization--a growing concern in the U.S.--exposes patients to unnecessary radiation, while also adding to rising healthcare costs, according to a study published online Aug. 24 in Radiology. In an interview, William R. Hendee, PhD, lead author, reviewed various methods by which medical imaging could be curtailed.

Radiology: Prelim study shows CE breast CT outperforms CT, mammo

Dedicated contrast-enhanced (CE) breast CT delivered significantly improved conspicuity of malignant breast lesions, including ductal carcinoma in situ (DCIS), compared with unenhanced breast CT and mammography, according to a study published in the September issue of Radiology.

Radiology: Rad role may evolve as image-guided biopsies trend up

CT, ultrasound and MRI have helped shift biopsy techniques away from more invasive approaches toward image-guided percutaneous techniques, according to a study published in the September issue of Radiology. The trend toward less-invasive approaches translates into enhanced safety and efficiency and could lead to more interaction between patients and radiologists.

CMS Webinar: Incentive payments to offset EHR adoption, not reimburse

The Centers for Medicare & Medicaid Services’ (CMS) EHR incentive payments are not considered reimbursement for money expended on EHR technology, but are intended to offset the cost associated with adoption and ongoing meaningful use, according to CMS during an Aug. 12 webinar.

CMS webinar: Eligible professionals can expect EHR incentives in 2011

Funding incentives for EHR use is the main goal of the Centers for Medicare & Medicaid Services' (CMS) meaningful use initiative, and there are incentive programs for both hospitals and eligible professionals, according to Elizabeth Holland, health insurance specialist at the Department of Health and Human Services, who spoke during a CMS-sponsored webinar Aug. 8.

Webinar: Stage 1 of meaningful use is for quality reporting acclimation

Stage 1 requirements for meaningful use incentives aim to strike a balance between the overall goal of EHR use and widespread adoption, while avoiding added work, said Jonathan Teich, MD, PhD, chief medical informatics officer at Elsevier Health Services, during a HIMSS webinar titled “Meaningful Use: Safety and Quality of Care.”

PORTALS

Advanced Visualization

Molecular Imaging

Integration Tools & Interoperability

More Portal Topics